---
type: "example"
title: "MedicinalProductDefinition Example: medicinalproductdefinition-example-equilidem-basics"
resource: "MedicinalProductDefinition"
example: "medicinalproductdefinition-example-equilidem-basics"
---
# MedicinalProductDefinition Example: medicinalproductdefinition-example-equilidem-basics

## Narrative

**Generated Narrative**

**Id** : equilidem-basics

**Identifier** : Equilidem25

**Combined Pharmaceutical Dose Form** : tablet

**Indication** : Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

**Legal Status Of Supply** : Prescription only medicine

**Classification** : ATC: B01A

**Ingredient** :

-   Equilidonium Phosphate
-   Calcium Carbonate

### Names

| \- | **Product Name** |
| --- | --- |
| \* | Equilidem 2.5 mg film-coated tablets |

### Cross References

| \- | **Product** |
| --- | --- |
| \* | Link to generic equivalent |

### Manufacturing/Business Operations

| \- | **Manufacturer** |
| --- | --- |
| \* | EquiliDrugCo Inc. |

## Example XML



```xml
<?xml version="1.0" encoding="UTF-8"?>
<MedicinalProductDefinition xmlns="http://hl7.org/fhir" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://hl7.org/fhir ../../schema/medicinalproductdefinition.xsd">
	<id value="equilidem-basics"/>
	<text>
		<status value="generated"/>
		<div xmlns="http://www.w3.org/1999/xhtml">
			<p>
				<b>
					Generated Narrative
				</b>
			</p>
			<p>
				<b>
					Id
				</b>
				: equilidem-basics
			</p>
			<p>
				<b>
					Identifier
				</b>
				: Equilidem25
			</p>
			<p>
				<b>
					Combined Pharmaceutical Dose Form
				</b>
				:
				<span title="Codes: {http://example.org.uk/fhir/dosefom tablet}">
					tablet
				</span>
			</p>
			<p>
				<b>
					Indication
				</b>
				: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
			</p>
			<p>
				<b>
					Legal Status Of Supply
				</b>
				:
				<span title="Codes: {http://example.org.uk/fhir/legalstatusofsupply POM}">
					Prescription only medicine
				</span>
			</p>
			<p>
				<b>
					Classification
				</b>
				:
				<span title="Codes: {http://www.whocc.no/atc/example B01A}">
					ATC: B01A
				</span>
			</p>
			<p>
				<b>
					Ingredient
				</b>
				:
			</p>
			<ul>
				<li>
					<span>
						Equilidonium Phosphate
					</span>
				</li>
				<li>
					<span>
						Calcium Carbonate
					</span>
				</li>
			</ul>
			<h3>
				Names
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Product Name
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						Equilidem 2.5 mg film-coated tablets
					</td>
				</tr>
			</table>
			<h3>
				Cross References
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Product
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						Link to generic equivalent
					</td>
				</tr>
			</table>
			<h3>
				Manufacturing/Business Operations
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Manufacturer
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						<span>
							EquiliDrugCo Inc.
						</span>
					</td>
				</tr>
			</table>
		</div>
	</text>
	<identifier>
		<system value="http://example.org.uk/fhir/product"/>
		<value value="Equilidem25"/>
	</identifier>
	<combinedPharmaceuticalDoseForm>
		<coding>
			<system value="http://example.org.uk/fhir/dosefom"/>
			<code value="tablet"/>
		</coding>
	</combinedPharmaceuticalDoseForm>
	<indication value="Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults."/>
	<legalStatusOfSupply>
		<coding>
			<system value="http://example.org.uk/fhir/legalstatusofsupply"/>
			<code value="POM"/>
			<display value="Prescription only medicine"/>
		</coding>
	</legalStatusOfSupply>
	<classification>
		<coding>
			<system value="http://www.whocc.no/atc/example"/>
			<code value="B01A"/>
		</coding>
	</classification>
	<ingredient>
		<text value="Equilidonium Phosphate"/>
	</ingredient>
	<ingredient>
		<text value="Calcium Carbonate"/>
	</ingredient>
	<name>
		<productName value="Equilidem 2.5 mg film-coated tablets"/>
	</name>
	<crossReference>
		<product>
			<reference>
				<reference value="MedicinalProductDefinition/genericEquilidonium"/>
			</reference>
		</product>
	</crossReference>
	<operation>
		<organization>
			<display value="EquiliDrugCo Inc."/>
			<!-- licence holder would use RegulatedAuthorization -->
		</organization>
	</operation>
</MedicinalProductDefinition>
```